<?xml version="1.0" encoding="UTF-8"?>
<ref id="R19">
 <label>19. </label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Nicholson</surname>
   <given-names>KG</given-names>
  </string-name>, 
  <string-name>
   <surname>Colegate</surname>
   <given-names>AE</given-names>
  </string-name>, 
  <string-name>
   <surname>Podda</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Stephenson</surname>
   <given-names>I</given-names>
  </string-name>, 
  <string-name>
   <surname>Wood</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>Ypma</surname>
   <given-names>E</given-names>
  </string-name>, 
  <etal/>
  <article-title>Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.</article-title>
  <source>Lancet</source>. 
  <year>2001</year>;
  <volume>357</volume>:
  <fpage>1937</fpage>â€“
  <lpage>43</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(00)05066-2</pub-id>
  <pub-id pub-id-type="pmid">11425416</pub-id>
 </mixed-citation>
</ref>
